Is Evonik Industries (XTRA:EVK) Fully Valued Or Is There Still Upside?
Evonik Industries (XTRA:EVK) has drawn fresh attention after its recent share move, with the price closing at €17.98. Investors are weighing this level against the latest fundamentals and valuation signals.
Recent trading has pushed Evonik Industries to a €17.98 share price after a 1 day share price return of 4.29%, capping a year to date share price return of 35.09% and a 1 year total shareholder return of 23.54%. This suggests that momentum has been building rather than fading.
Scan how Evonik Industries compares with other materials stocks showing strong price moves and solid fundamentals in our hand-picked 174 high quality undervalued stocks.
After a 35.09% year to date climb and a share price close to its €18.05 analyst target, Evonik Industries now sits at a crossroads. Do the valuation numbers still point to meaningful upside, or has most of the opportunity already been priced in?
Most Popular Narrative: 2% Undervalued
Evonik Industries currently trades at €17.98 against a widely followed narrative fair value of about €18.28. The gap is small but still frames the stock as modestly cheap based on those assumptions and the 6.14% discount rate used in the model.
Ongoing portfolio shift towards high-margin specialty chemicals and away from commoditized businesses aligns with strict regulatory trends and customer demands for eco-friendly, high-value additives, supporting both top-line growth and structural margin uplift over the long term.
See why 29 investors see Evonik Industries as 2% undervalued.
Result: Fair Value of €18.28 (UNDERVALUED)
Still, the story can break if weak demand in construction and automotive lingers, or if the commodity-heavy C4 operations keep dragging on overall profitability.
Find out about the key risks to this Evonik Industries narrative.
Another View On Evonik Industries’ Valuation
The story looks very different once the focus shifts from fair value narratives to the actual P/E. Evonik Industries trades on 66.4x earnings, while the fair ratio sits at 28.8x and the European chemicals group averages 17.6x. That is a wide gap. Is the market mispricing risk, or just paying up early for future recovery?
For a closer look at how these earnings multiples compare with the underlying fundamentals, See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Sentiment around Evonik Industries is mixed, with both concerns and bright spots sitting in plain view. Act promptly, review the underlying data for yourself, and weigh the 2 key rewards and 3 important warning signs.
Looking for more investment ideas beyond Evonik Industries?
If Evonik Industries has sharpened your focus, do not stop here. Broaden your watchlist with fresh ideas that match your style and risk tolerance.
- Explore higher risk opportunities by scanning the 136 elite penny stocks with strong financials that already clear solid financial filters.
- Prioritize quality at a sensible entry point by reviewing our hand picked 174 high quality undervalued stocks that combine stronger balance sheets with appealing valuations.
- Keep capital productively allocated by tracking income ideas in the 160 dividend fortresses that focus on resilient payout profiles.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com